Honoring Dr. Jeffrey S. Weber

Ensuring Dr. Weber’s values
live on…

A donation to the Jeffrey S. Weber Memorial Fund creates a lasting, positive impact on the future of cancer research and treatment. This fund, established in honor of Dr. Jeffrey S. Weber, a pioneering immunotherapy researcher, is dedicated to supporting early-career scientists in the field of cancer immunotherapy. Through your generous contribution, you help cultivate the next generation of innovators and leaders in oncology.

By donating $1,000, you fund one Young Investigator Travel Award, allowing a promising young scientist to attend the Society for Immunotherapy of Cancer (SITC) Annual Meeting. This prestigious event is a pivotal opportunity for young researchers to present their findings, network with established professionals, and gain exposure to the latest advancements in cancer immunotherapy. For many, this experience becomes a springboard for future breakthroughs in the field. 

Contribute to the Jeffrey S. Weber Memorial Fund

SITC established the Jeffrey S. Weber Memorial Fund to honor Dr. Weber and his many contributions to the field of immuno-oncology. Your donation to this fund will help emerging leaders in immuno-oncology who are focused on a novel approach to advancing the field of immunology and cancer immunotherapy. The fund will support travel awards to the SITC Annual Meeting for early career investigators. 

Watch Dr. Weber's FAIO Video

Read JITC's memorial to Dr. Weber

Jeffrey S Weber’s passing on 18 August 2024 brought forth a wave of emotions and fond memories for a colleague considered to be one of the major forces in the advancement of tumor immunology and immunotherapy.

Read More

About the Forward Fund

Learn more about the SITC Forward Fund >

SITC established the Forward Fund in 2012, to stimulate the development and application of cancer immunology and immunotherapy by financially supporting its education and research.

Contributions to the Forward Fund help provide grants to promising young post-doctoral researchers, advocate for more young scientists to enter the field of cancer immunotherapy research and much more.